Login to Your Account



NeoPharm, FDA Define Plans For IL13's Phase III Program

By Aaron Lorenzo


Monday, February 9, 2004
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription